Buprenorphine And Naloxone Tablet
Product Images NDC 72162-1346

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 72162-1346). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

FDA Label Image

Chemical Structure (Buprenorphine 02)

FDA Label Image

Image (Buprenorphine 03)

FDA Label Image

Label (Lbl721621346)

Label (Lbl721621346)
This text provides information about Buprenorphine and Naloxone Sublingual Tablets, highlighting dosage, storage instructions, emergency care for accidental ingestion by children, manufacturer details, and the composition of each tablet. It also includes a website link for further details.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.